Unique Ingredient Identifier 3980JIH2SW is listed as a unspecified ingredient
NCIT | C66549 |
RXCUI | 235496 |
UNII 3980JIH2SW SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
BUCCAL | FILM | 0.47 MG |
BUCCAL | FILM, SOLUBLE | 0.76 MG |
IM - IV | INJECTABLE | 0.16 % |
IM - IV | INJECTION | 1.47 % |
INTRALESIONAL | SUSPENSION, INJECTION | 0.68 % |
INTRAMUSCULAR | INJECTION | 2.56 % |
INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION | 0.18 %W/V |
INTRAMUSCULAR | SUSPENSION, EXTENDED RELEASE | 0.6 % |
INTRAMUSCULAR | SUSPENSION, INJECTION | 0.68 %W/V |
INTRASYNOVIAL | SUSPENSION, INJECTION | 0.68 % |
INTRAVENOUS | INJECTION | 2.56 % |
INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 0.18 % |
INTRAVENOUS | SOLUTION, INJECTION | 0.35 % |
IONTOPHORESIS | PATCH, CONTROLLED RELEASE | 14.2 MG |
IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 1.32 % |
OPHTHALMIC | SOLUTION | 0.19 % |
ORAL | SOLUTION | 25 MG/5ML |
ORAL | SOLUTION, LIQUID | ADJPH |
ORAL | SUSPENSION | 32.5 MG/5ML |
ORAL | TABLET | 1.38 MG |
SOFT TISSUE | SUSPENSION, INJECTION | 0.68 % |
SUBCUTANEOUS | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 0.022 % |
SUBCUTANEOUS | SUSPENSION, INJECTION | 0.11 % |
TOPICAL | CREAM, AUGMENTED | 0.2 %W/W |
TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 0.27 %W/W |
TOPICAL | EMULSION, CREAM | 0.27 %W/W |
TOPICAL | LOTION | 0.3 %W/W |
TOPICAL | LOTION, AUGMENTED | 0.2 %W/W |
TOPICAL | PATCH, CONTROLLED RELEASE | 14.2 MG |
TOPICAL | SHAMPOO, SUSPENSION | NA |
TOPICAL | SOLUTION | 0.1 %W/V |